JPWO2019237152A5 - - Google Patents

Download PDF

Info

Publication number
JPWO2019237152A5
JPWO2019237152A5 JP2020569792A JP2020569792A JPWO2019237152A5 JP WO2019237152 A5 JPWO2019237152 A5 JP WO2019237152A5 JP 2020569792 A JP2020569792 A JP 2020569792A JP 2020569792 A JP2020569792 A JP 2020569792A JP WO2019237152 A5 JPWO2019237152 A5 JP WO2019237152A5
Authority
JP
Japan
Prior art keywords
prebiotic
sugar cane
fiber material
bowel disease
inflammatory bowel
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
JP2020569792A
Other languages
English (en)
Japanese (ja)
Other versions
JP2021527104A (ja
JP7385930B2 (ja
Publication date
Application filed filed Critical
Priority claimed from PCT/AU2019/050604 external-priority patent/WO2019237152A1/en
Publication of JP2021527104A publication Critical patent/JP2021527104A/ja
Publication of JPWO2019237152A5 publication Critical patent/JPWO2019237152A5/ja
Application granted granted Critical
Publication of JP7385930B2 publication Critical patent/JP7385930B2/ja
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

JP2020569792A 2018-06-15 2019-06-12 サトウキビ由来の全植物繊維抽出物を使用した炎症性腸疾患の治療のための製剤 Active JP7385930B2 (ja)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
AU2018902145 2018-06-15
AU2018902145A AU2018902145A0 (en) 2018-06-15 Preparation for the Treatment of Inflammatory Bowel Disease using a Whole Plant Fibre Extract from Sugarcane
PCT/AU2019/050604 WO2019237152A1 (en) 2018-06-15 2019-06-12 Preparation for the treatment of inflammatory bowel disease using a whole plant fibre extract from sugarcane

Publications (3)

Publication Number Publication Date
JP2021527104A JP2021527104A (ja) 2021-10-11
JPWO2019237152A5 true JPWO2019237152A5 (enExample) 2022-06-10
JP7385930B2 JP7385930B2 (ja) 2023-11-24

Family

ID=68841796

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2020569792A Active JP7385930B2 (ja) 2018-06-15 2019-06-12 サトウキビ由来の全植物繊維抽出物を使用した炎症性腸疾患の治療のための製剤

Country Status (6)

Country Link
US (1) US20210138002A1 (enExample)
EP (1) EP3806879A4 (enExample)
JP (1) JP7385930B2 (enExample)
AU (1) AU2019285375B2 (enExample)
CA (1) CA3103831A1 (enExample)
WO (1) WO2019237152A1 (enExample)

Families Citing this family (26)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US11103470B2 (en) 2017-11-22 2021-08-31 Axcess Global Sciences, Llc Non-racemic beta-hydroxybutyrate compounds and compositions enriched with the R-enantiomer and methods of use
US11241403B2 (en) 2016-03-11 2022-02-08 Axcess Global Sciences, Llc Beta-hydroxybutyrate mixed salt compositions and methods of use
US10973786B2 (en) 2016-03-11 2021-04-13 Axcess Global Sciences, Llc R-beta-hydroxybutyrate, S-beta-hydroxybutyrate, and RS-beta-hydroxybutyrate mixed salt compositions
US10736861B2 (en) 2016-03-11 2020-08-11 Axcess Global Sciences, Llc Mixed salt compositions for producing elevated and sustained ketosis
US10973792B2 (en) 2019-02-13 2021-04-13 Axcess Global Sciences, Llc Racemic beta-hydroxybutyrate mixed salt-acid compositions and methods of use
US11185518B2 (en) 2017-12-19 2021-11-30 Axcess Global Sciences, Llc S-beta-hydroxybutyrate compounds and compositions enriched with S-enantiomer
US12496283B2 (en) 2016-04-19 2025-12-16 Axcess Global Sciences, Llc Administration of R-beta-hydroxybutyrate and related compounds in humans
US11202769B2 (en) 2017-11-22 2021-12-21 Axcess Global Sciences, Llc Ketone body esters of s-beta-hydroxybutyrate and/or s-1,3-butanediol for modifying metabolic function
US12109182B2 (en) 2016-04-19 2024-10-08 Axcess Global Sciences, Llc Administration of R-beta-hydroxybutyrate and related compounds in humans
US11944598B2 (en) 2017-12-19 2024-04-02 Axcess Global Sciences, Llc Compositions containing s-beta-hydroxybutyrate or non-racemic mixtures enriched with the s-enatiomer
US10925843B2 (en) 2018-04-18 2021-02-23 Axcess Global Sciences, Llc Compositions and methods for keto stacking with beta-hydroxybutyrate and acetoacetate
US12329734B2 (en) 2017-12-19 2025-06-17 Axcess Global Sciences, Llc Use of S-beta-hydroxybutyrate compounds for induction and maintenance of flow
US11806324B2 (en) 2018-04-18 2023-11-07 Axcess Global Sciences, Llc Beta-hydroxybutyric acid compositions and methods for oral delivery of ketone bodies
US12090129B2 (en) 2017-11-22 2024-09-17 Axcess Global Sciences, Llc Non-racemic beta-hydroxybutyrate compounds and compositions enriched with the R-enantiomer and methods of use
US11241401B2 (en) 2020-02-06 2022-02-08 Axcess Global Sciences, Llc Enantiomerically pure r-beta-hydroxybutyrate mixed salt-acid compositions
US10980772B2 (en) 2018-08-27 2021-04-20 Axcess Global Sciences, Llc Compositions and methods for delivering tetrahydrocannabinol and ketone bodies
US11419836B2 (en) 2019-02-13 2022-08-23 Axcess Global Sciences, Llc Racemic and near racemic beta-hydroxybutyrate mixed salt-acid compositions
US11129802B2 (en) 2018-08-27 2021-09-28 Axcess Global Sciences, Llc Compositions and methods for delivering cannabidiol and ketone bodies
US12472200B2 (en) 2019-05-15 2025-11-18 Axcess Global Sciences, Llc Autobiotic compositions and method for promoting healthy gut microbiome
US11950616B2 (en) 2019-06-21 2024-04-09 Axcess Global Sciences, Llc Non-vasoconstricting energy-promoting compositions containing ketone bodies
US11033553B2 (en) 2019-06-21 2021-06-15 Axcess Global Sciences, Llc Non-vasoconstricting energy-promoting compositions containing ketone bodies
US12167993B2 (en) 2019-06-21 2024-12-17 Axcess Global Sciences, Llc Non-vasoconstricting energy-promoting compositions containing ketone bodies
US11969430B1 (en) 2023-03-10 2024-04-30 Axcess Global Sciences, Llc Compositions containing paraxanthine and beta-hydroxybutyrate or precursor for increasing neurological and physiological performance
US12186297B2 (en) 2020-08-26 2025-01-07 Axcess Global Sciences, Llc Compositions and methods for increasing lean-to-fat mass ratio
WO2024026529A1 (en) * 2022-08-01 2024-02-08 Health Food Symmetry Pty Ltd Preparation for the treatment of non-alcoholic fatty liver disease (nafld)
BE1031643B1 (nl) * 2023-05-26 2025-01-03 Synero Bv Functionele drank alsook werkwijze voor het vervaardigen en stabiliseren hiervan

Family Cites Families (16)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
NO320546B1 (no) * 2003-12-12 2005-12-19 Nova Biotics As Prebiotiske kombinasjonsprodukter
US20060093592A1 (en) * 2004-10-04 2006-05-04 Nutracea Synbiotics
US20080227753A1 (en) * 2007-02-26 2008-09-18 Kun Lian Nano-sized Bagasse Fiber
US9245263B2 (en) * 2009-06-23 2016-01-26 Jwl Ip Holdings Llc Systems and methods for scripted content delivery
AU2010334993B2 (en) 2009-12-22 2015-07-09 Probi Ab Non-fermented compositions comprising a cereal based fraction and a probiotic and uses thereof
CN104168779A (zh) * 2012-03-05 2014-11-26 格拉图克技术私人有限公司 膳食补充剂
WO2014162303A1 (en) * 2013-04-05 2014-10-09 Gratuk Technologies Pty Ltd Use of a dietary fibre supplement in a food formulation
CN103355728A (zh) * 2013-07-01 2013-10-23 福建省农业科学院农业工程技术研究所 一种果汁的固定化半连续乳酸发酵方法
WO2015071811A1 (en) * 2013-11-18 2015-05-21 Kfsu Ltd Dietary supplement for the treatment of acid reflux and gastro-oesophageal reflux disease (gord/gerd)
JP5852207B2 (ja) 2013-11-29 2016-02-03 喜信 大城 サトウキビの難消化性食物繊維の製造方法
JP2015202057A (ja) * 2014-04-11 2015-11-16 喜信 大城 食物繊維入りヨーグルトの製造方法
WO2015182530A1 (ja) * 2014-05-24 2015-12-03 アテリオ・バイオ株式会社 難消化性物質及びその製造方法
CA2988787C (en) 2014-06-13 2024-06-04 Gratuk Technologies Pty Ltd Use of dietary fibre material for the treatment of the effects of chronic inflammation and associated conditions
CN104814365A (zh) * 2015-05-29 2015-08-05 郭心仪 鹅饲料的制备方法
CN105685486A (zh) * 2016-01-29 2016-06-22 刘健 一种天然高纤维无臭型牛羊饲料的制备方法
CN106883968A (zh) * 2017-04-24 2017-06-23 贵州省仁怀市茅台镇永泰酒业股份有限公司 一种杨梅果酒生产方法

Similar Documents

Publication Publication Date Title
JPWO2019237152A5 (enExample)
US10617728B2 (en) Probiotics and prebiotics compound preparation and processing method thereof
CN116270773A (zh) 黄金奇异果组合物及其制备和使用方法
JP2019520340A5 (enExample)
CN102458152A (zh) 具有β-1,3和β-1,4/1,6键的β-低聚半乳糖的协同混合物
JP2013517784A5 (enExample)
KR102544149B1 (ko) 락토바실러스 헬베티쿠스 균주 및 이를 포함하는 염증성 질환의 예방 또는 치료용 조성물
CN102711778A (zh) 利用动物双歧杆菌细菌或含有这种细菌的发酵乳制品减轻胃肠炎症的方法
Liu et al. Efficacy of Bifidobacterium tetragenous viable bacteria tablets for cancer patients with functional constipation
CN114672436B (zh) 一株嗜酸乳杆菌及其应用
CN116173078A (zh) 一种发酵粘液乳杆菌在制备预防或延缓亨廷顿舞蹈症产品中的应用
CN119343144A (zh) 发酵乳杆菌菌株单独或与酿酒酵母组合用于预防和/或治疗阴道念珠菌病的用途
CN108403725A (zh) 用于治疗消化道溃疡的组合物及其应用
CN112023030A (zh) 一种护理骨关节新组氨糖益生菌骨胶原蛋白肽配方
CN112888448B (zh) 单形巨单胞菌在预防和/或治疗代谢性疾病中的用途
CN102742653B (zh) 一种健脑安神益生菌羊奶片及其制备方法
Wei et al. The impact of combined therapy with Lactobacillus acidophilus and montmorillonite powder on the inflammatory response in pediatric rotavirus enteritis
Staka et al. Impact of oat-based products on human gastrointestinal tract
KR20190143337A (ko) 류코노스톡속 균주를 포함하는 장 기능 개선용 조성물
WO2014086258A1 (zh) 山药糖蛋白提高脑细胞线粒体氧化代谢酶活性的用途
CN106349318B (zh) 一种五环三萜化合物在制备治疗肥胖症药物中的应用
WO2019242560A1 (zh) 一种中药组合物及其在调节肠道微生物中的用途
US20230302066A1 (en) Probiotic composition for treatment of oral candida infections
CN117241808A (zh) 用于治疗和预防胃肠炎症的组合物和方法
Li et al. Research progress of traditional Chinese medicine compound in the treatment of gout based on intestinal flora